FTC wins $448 million disgorgement from AbbVie and Besins
AbbVie has said it will appeal its loss against the Federal Trade Commission in a lawsuit for monopolising Androgel through sham litigation, as a Pennsylvania federal court ordered the drugmaker and Besins Healthcare to pay $448 million to consumers.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Subscribe now
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10